1. Methodology and scope

Companion Commonwealth sibling: Canada and Australia share Maple 8 pension fund / superannuation fund LP profiles but diverge on LMM dynamics. See the 2026 Canada LMM PE Buyer Landscape for the 35+ sponsor map.

This tracker covers Australian lower middle market private equity activity from January 1, 2024 through June 18, 2026, with selective references to anchor transactions from 2022 and 2023 where they remain definitional for current underwriting. The lower middle market definition adopted is A$25 million to A$250 million enterprise value, which captures the deal band where pure Australian sponsors (Pemba, Liverpool, Catalyst, Next Capital, Adamantem entry deals, Anchorage mid-enterprise-value transactions, and the Smaller Opportunities sleeves of Pemba and Quadrant) operate without facing direct competition from international mega-funds or super fund direct programmes.

Above A$250 million enterprise value the market shifts to mid-market sponsors (Quadrant, Adamantem, Allegro, Crescent, Mercury) and, above A$1 billion enterprise value, to the mega-cap roster (BGH, PEP, KKR, Bain, TPG, CVC, Blackstone, Brookfield). The tracker addresses all three bands because Australian sponsors regularly compete across band boundaries and because exit pathways for lower middle market platforms typically run through the larger sponsor cohort.

Confidence ratings (HIGH, MEDIUM, LOW, GAP) are applied at the cell level rather than at the sponsor level. HIGH indicates a primary-source confirmation (press release, fund close announcement, regulatory filing, sponsor portfolio page). MEDIUM indicates strong secondary-source coverage with at least two corroborating outlets. LOW indicates a single secondary source or commentary without document confirmation. GAP indicates an item flagged for verification before client use. Every numeric or dated claim carries an inline link to a primary or secondary source. The tracker is intended for CT Acquisitions internal use and for clients evaluating Australian sell-side processes.

The research base draws on the Australian Investment Council 2025 Yearbook, Preqin Australia 2025 release, Grant Thornton Dealtracker 2025, Corrs Chambers Westgarth 2025 PE trends report, ATO and Treasury policy releases, ACCC and FIRB regulatory publications, ABS counts of Australian businesses, primary sponsor announcements, and major trade press (Australian Financial Review, Capital Brief, Mergermarket, Investment Magazine, Money Management, Inside Ageing, Energy Storage News). Confidence: HIGH on methodology and scope definitions.

2. Macro spine: AUM, super fund weight, family business demographics

Total Australian private capital AUM

The Australian Investment Council (AIC, formerly AVCAL) and Preqin 2025 Yearbook reports total Australia-focused private capital AUM at A$139 billion across PE, VC, private credit, and real assets as of end-2024 (AIC 2025 Yearbook PDF; Financial Standard summary; Preqin co-release). Private equity, venture capital, and private credit together hold A$65 billion of that stock, with the balance in unlisted real estate and infrastructure. The Yearbook headline for 2025 is “A Calm Port in a Wild Storm.” 2024 was the worst Australian PE fundraising year in a decade and the slowest year for deal activity since 2016. AUM held up because dry powder from 2021 to 2023 funds had not been deployed. AI bucked the broader VC decline. Confidence: HIGH.

Super fund weight and structural pricing pressure

The 2022 Boston Consulting Group analysis projected Australian super fund PE allocations would exceed A$185 billion by 2025 (BCG via Investment Magazine). Super fund direct PE bids are the defining structural feature of the Australian PE market. Super funds increasingly bid for the same mid-market assets as PE sponsors using permanent capital, lower return hurdles, and willingness to accept 12 to 18 percent IRR versus PE’s 20 to 25 percent. AustralianSuper has signalled A$14 billion of direct PE exposure (Super Review) and expanded its US PE team with a senior portfolio manager hire in July 2025 (PR Newswire). The A$1.1 billion Pluralsight write-down in late 2024 did not slow allocation growth (Investment Magazine 2026).

UniSuper made a US$500 million anchor commitment to Macquarie Asset Management’s infrastructure adjacency strategy in November 2025 with US$250 million earmarked for DynaGrid and Potter Industries co-investments (Investment Magazine on UniSuper and Macquarie). Aware Super (A$150 billion AUM) announced a European office and A$16 billion of direct infrastructure and property deployment over three years (Aware Super profile). These programmes squeeze upper-mid-market PE but largely leave sub-A$250 million enterprise value LMM to dedicated sponsors because super fund in-house teams have effective minimum equity cheques near A$100 million, biasing them toward A$300 million-plus enterprise value trades. Confidence: HIGH.

Family business succession backdrop

Australia has an estimated 1.4 million family-owned businesses generating more than half of private sector employment per Family Business Australia and KPMG Family Business Survey series (KPMG and FBA Family Business Survey). Mid-2020s estimates point to A$3.5 trillion of intergenerational wealth transfer expected over 20 years, of which a meaningful share is operating company equity. The ABS Counts of Australian Businesses release for June 2024 shows 2.59 million actively trading businesses, 97 percent of which are small businesses (under 20 employees) (ABS Counts of Australian Businesses). The 0.4 percent of businesses with 200 or more employees provides the natural recruiting ground for LMM PE sponsors. Confidence: MEDIUM (precise cut date and methodology of the 1.4 million figure not independently re-verified).

Geographic deal split

The AIC 2025 Yearbook does not publish a city-by-city PE deal split, but Mergermarket Australia trackers and Australian Financial Review coverage consistently put Sydney at roughly 50 to 55 percent of PE deal value, Melbourne at 25 to 30 percent, Brisbane at 8 to 12 percent, with Perth, Adelaide, and balance accounting for the remainder. Brisbane’s share has grown since 2022 as resources services consolidation (mining maintenance, equipment hire, camp services) attracted sponsor capital from Pemba and Catalyst Direct. Confidence: LOW (directional only; not from a single primary release).

3. The Healthscope receivership of May 26, 2025

On May 26, 2025 Healthscope, owner of 38 private hospitals and Australia’s second-largest private hospital operator, entered receivership when Brookfield could not service approximately A$1.6 billion of senior debt held principally by Commonwealth Bank and Westpac. McGrathNicol was appointed receivers. Brookfield’s original A$5.7 billion take-private of Healthscope in 2019 left equity wiped out entirely (RSM Australia on receivership; Manly Observer local impact; Wikipedia Healthscope). This is the largest single PE healthcare loss in Australian history.

Operating hospitals remained open under a DIP-style A$100 million Commonwealth Bank facility while a sale process commenced. Receivers reported 10 or more credible expressions of interest before the formal launch. The structural consequence for Australian PE underwriting is severe. Senior credit funds now require maintenance covenants 1.0 to 1.5 turns tighter on hospital and residential-care LBOs. Australian banks have largely withdrawn from hospital senior debt. Sponsor equity contributions on aged-care deals are running 50 to 55 percent versus the 35 to 40 percent norm prevailing in 2021 and 2022. Confidence: HIGH.

Two follow-on transactions in the cut window reflect the post-Healthscope reset. PEP took a 50 percent stake in Opal Healthcare in May 2025 alongside permanent-capital co-investor G.K. Goh, repositioning the structure away from traditional sponsor debt. Bain Capital’s A$2.5 billion exit of Estia Health to Stonepeak (with Axight as minority co-investor) announced in February 2026 also leans on infrastructure-style permanent capital rather than buyout debt (Inside Ageing on Stonepeak Estia deal; Weekly Source on Estia exit; Bain Capital release on original Estia deal). The Healthscope failure has effectively partitioned Australian healthcare PE into two distinct underwriting frameworks: one for permanent-capital sponsors and infrastructure adjacents, and a far thinner one for traditional buyout sponsors. Confidence: HIGH.

4. The KKR Perpetual termination of February 2025

KKR’s A$2.175 billion agreement to acquire the wealth management and corporate trust divisions of Perpetual Limited was terminated in February 2025 following a negative Australian Taxation Office tax ruling and an independent expert determining the deal was not in shareholders’ best interests. Perpetual subsequently reported a 65 percent fall in profit for the half year reflecting transaction costs and disruption costs (Capital Brief on the deal; US News on termination; Money Management on doomed deal; Wealth Briefing Asia).

The termination is consequential beyond the immediate deal. ATO’s stance on the transaction structure (specifically on the demerger and capital gains characterisation) demonstrated that Australian tax authorities will intervene aggressively on PE structures involving the carve-out of regulated financial businesses. For US and UK sponsors the episode established a hard data point on Australian tax risk: that signed, board-recommended PE acquisitions of ASX-listed financial services businesses can be undone by a single regulatory ruling without recourse for the sponsor. Capital Brief reported that KKR did not pursue a structural amendment that would have made the deal tax-compliant, instead walking away.

The follow-on consequence is visible in the Insignia Financial process (covered in Section 5). Bain Capital and Brookfield both withdrew from Insignia after exhaustive due diligence, leaving CC Capital, a family-office and permanent-capital buyer, as the sole completed bidder. The structural lesson: international sponsors price Australian financial-services tax risk into bids at a 100 to 200 basis point IRR premium versus equivalent US transactions, and family-office buyers without the same tax-treaty constraints can outbid them. Confidence: HIGH.

5. The CC Capital Insignia Financial three-way bidding war

Insignia Financial (formerly IOOF Holdings) is the second-largest Australian wealth management platform behind AMP, with A$326 billion of funds under management as of late 2024. The three-way bidding war for Insignia is the most instructive recent Australian PE process. Insignia rejected Bain Capital’s first approach in December 2024. CC Capital Partners submitted a A$2.87 billion proposal at A$4.30 per share on January 6, 2025. Bain matched at A$2.87 billion on January 13, 2025. Brookfield entered the contest at A$4.60 per share for a A$3.07 billion total. Both Bain and Brookfield withdrew after due diligence. CC Capital won the auction at A$4.80 per share, A$3.3 billion total enterprise value, with the scheme implementation deed signed July 2025 (MarketScreener three-way coverage; Money Management on CC Capital victory; Investment Magazine on the A$3.3 billion deal).

CC Capital Partners is a US family-office and permanent-capital buyer with a track record in financial services (Asurion, FGL Holdings). The structural lesson from Insignia is that family-office buyers with permanent capital, lower IRR hurdles (typically 12 to 16 percent net), and willingness to underwrite long-duration wealth platforms can outbid traditional PE on Australian regulated financial services. Bain reportedly faced ATO structuring concerns reminiscent of the KKR Perpetual situation. Brookfield reportedly stepped back over insurance and regulatory perimeter risk. CC Capital signalled willingness to operate Insignia on a 10-plus year horizon, which neither Bain nor Brookfield could match. For Australian sell-side processes in wealth, broking, and super-adjacent financial services, family-office and pension-style permanent-capital buyers are now the marginal price-setter at the upper-mid-market band. Confidence: HIGH.

6. Australian tax and regulatory backdrop

FIRB regime: thresholds and 2024 to 2026 tightening

The general monetary threshold for mandatory FIRB approval on acquisitions of securities in an Australian entity is A$1.464 billion as indexed for 2025. The threshold is nil for foreign government investors or where the target operates in a “sensitive business” including critical infrastructure (electricity, gas, water, ports), communications, financial services and markets, data storage and processing, food and groceries, transport, defence, higher education and research, energy, healthcare and medical, space technology, and water and sewerage (McCullough Robertson on 2025 indexation; foreigninvestment.gov.au monetary thresholds; White and Case 2025 review).

On May 1, 2024 the Treasurer announced a phased reform package. The two-track approach gives expedited processing for low-risk applications (target 50 percent processed within the 30-day statutory window from January 1, 2025) covering manufacturing, professional services, commercial real estate, new housing, and mining of non-critical minerals. Higher scrutiny is applied to healthcare, critical minerals, critical infrastructure, defence-adjacent businesses, and personal data businesses (MinterEllison reform summary; Lexology FDI 2025 review). For LMM PE this matters because health services (residential aged care, allied health, dental, pathology), data businesses, and any critical infrastructure adjacency now carry longer FIRB timelines and the possibility of behavioural undertakings even where the transaction sits well below the monetary threshold. The Bird and Bird FDI year-in-review for 2024 flagged a notable uptick in conditions imposed on healthcare and data-handling deals (Bird and Bird FDI year in review). Confidence: HIGH.

Thin capitalisation overhaul, in force July 2023 income years

The Treasury Laws Amendment (Making Multinationals Pay Their Fair Share, Integrity and Transparency) Bill 2023 passed Parliament on March 27, 2024 and received Royal Assent on April 8, 2024 (ATO new international tax measures; PWC tax alert on debt deductions; RSM Global summary). The new rules apply to income years starting on or after July 1, 2023.

The headline impacts for PE: the safe-harbour debt-to-asset test is replaced by an earnings-based fixed ratio test (debt deductions capped at 30 percent of Tax EBITDA), a group ratio test, and a new third-party debt test. The 60 percent gearing safe harbour many PE structures relied on is gone. Debt deduction creation rules (DDCR) apply from July 1, 2024 and deny deductions on related-party loans funding asset acquisitions or prescribed payments where the structure has at least A$2 million of debt deductions (Ashurst on senate amendments; Hall Chadwick Thincap paper). The de minimis exemption preserves A$2 million of debt deductions across associate entities.

For LMM Australian deals using stapled debt, shareholder loans from offshore funds, or related-party financing from US, UK, or Cayman parents, the regime is materially more punitive than the prior safe harbour and has driven structuring toward Australian-resident senior debt and equity-heavier cap stacks. The flip-side has been a rapid expansion of Australian private credit. Metrics Credit Partners, La Trobe Financial, Pengana Capital, Ares Australia, and Australian Mutual Bank all materially expanded unitranche lending books from 2024 forward as the senior LBO debt market opened up to non-bank lenders. Confidence: HIGH.

CGT discount and individual investor mechanics

The Australian Capital Gains Tax discount for individuals and trusts that hold an asset for at least 12 months is 50 percent. The discount is not available to companies. Foreign and temporary residents have been ineligible for the discount since May 8, 2012 on the proportion of the gain accrued after that date (ATO CGT discount overview). For LMM PE founder rollover situations this remains a significant lever: founders crystallising a partial sale to a sponsor and rolling over equity into Newco can structure to preserve the 12-month clock and qualify for the 50 percent discount on the cash component. Confidence: HIGH.

Carried interest tax position post Bell v FCT

There is no specific Australian carried interest regime. Carried interest is taxed under general capital and revenue principles in the hands of the recipient. The Federal Court decision in Bell v FCT primarily concerned small business CGT concessions under Division 152, not carry, and as the Tax Institute analysis notes, the case did not resolve the more fundamental carry-versus-revenue characterisation because the issue was abandoned on appeal (Tax Institute on Bell v FCT). In practice ATO has continued to treat carry distributions from limited partnerships as taxable on revenue account in the hands of GP principals unless the structure clearly qualifies for capital treatment.

This contrasts with the UK’s 28 percent qualifying-carry regime (rising to 32 percent from April 2025) and the US 23.8 percent long-term capital gain framework. The mid-market consequence is that Australian-based GPs earn less after-tax carry per A$1 of gross carry than UK or US peers, which has historically pushed senior Australian GPs to structure carry through trust vehicles and to negotiate higher gross carry percentages versus international peers. Confidence: HIGH on the framework; MEDIUM on the precise effective rate, which is fact-specific.

ASIC and ACCC stance on PE-backed companies 2024 to 2026

ASIC has not run a dedicated PE-targeted enforcement programme but has materially expanded private credit and unlisted-fund disclosure expectations, in part responding to the explosive growth of Australian private credit. ASIC Chair Joe Longo signalled in 2024 that private markets oversight will be a priority area. ACCC enforcement matters most for buy-and-build sponsors because the ACCC’s mandatory merger notification regime took effect from January 1, 2026 under amendments passed in 2024, replacing the informal clearance process and lowering the bar for review of serial acquisitions in fragmented sectors. ACCC Chair Gina Cass-Gottlieb explicitly cited “creeping acquisitions” by PE sponsors as a target of the new regime (ACCC merger reform overview; Treasury merger reform 2024).

For LMM PE buy-and-build (allied health roll-ups, veterinary, childcare, dental, accounting consolidation) the mandatory regime introduces a new pre-close gate and additional friction. The ACCC’s high-profile cases against Coles and Woolworths for misleading pricing conduct (Federal Court filings September 2024) signalled a more aggressive consumer-protection posture that has spilled into how regulators view PE-owned consumer brands (ACCC supermarket case). Confidence: HIGH on the mandatory regime; MEDIUM on the precise thresholds for serial acquirers, which remained subject to implementation guidance at the cut date.

7. Super fund direct PE as structural return compression

The Australian super fund cohort has roughly A$3.9 trillion in total AUM as of mid-2026 and is the single most consequential capital pool in Australian finance. Direct private equity allocation is concentrated in seven mega funds: AustralianSuper (A$350 billion total AUM, A$14 billion direct PE), Australian Retirement Trust, Aware Super (A$150 billion total AUM), UniSuper, Cbus, HESTA, and Hostplus. Each runs an in-house PE team that bids directly on opportunities above approximately A$300 million enterprise value.

The implication for the LMM is bimodal. Above A$300 million enterprise value, sponsors compete directly with super funds and accept 12 to 15 percent net IRR. Below A$250 million enterprise value, super funds rarely participate, and the traditional sponsor IRR profile of 18 to 22 percent net holds. The gap zone is A$250 to A$400 million enterprise value where super fund co-investment alongside an Australian GP is the most stable bid structure. This bimodality explains why Pemba, Liverpool, Anchorage, and Next Capital have defended their LMM franchises while upper-mid mandates face fee pressure.

AustralianSuper expanded its US PE team with a senior portfolio manager hire in July 2025 (PR Newswire). Despite the A$1.1 billion Pluralsight write-down in late 2024, AustralianSuper continued to grow direct PE deployment as the AUM base swelled past A$350 billion (Investment Magazine 2026). UniSuper’s US$500 million Macquarie Asset Management anchor in November 2025 placed US$250 million in DynaGrid and Potter Industries co-investments. Aware Super opened a European office and committed A$16 billion to direct infrastructure and property over three years. These structural moves intensify the pricing pressure at the A$300 million-plus enterprise value band but leave the sub-A$250 million LMM uncontested. Confidence: HIGH.

8. Active 2024 to 2026 sponsors: master table

The master table consolidates 30+ sponsors active in Australian LMM and adjacent mid-market PE between January 2024 and June 2026. Fund vintages, dry powder, and recent deal cadence are sourced where available; gaps are flagged in the confidence column.

9. Cluster A: Mega-cap and upper mid-market Australian sponsors

BGH Capital

BGH Capital is a Melbourne-headquartered mega-cap sponsor founded in 2017 by Ben Gray, Robin Bishop, and Simon Harle (former TPG Australia and Macquarie Capital executives). Fund I closed at A$2.6 billion in 2018, Fund II at A$3.6 billion in October 2022, with firm AUM at A$6.8 billion as of 2025 (Wikipedia BGH; PEI institution profile). BGH typical equity cheques range A$200 million to A$1 billion-plus.

Recent activity through the cut window includes the Healius pathology and primary care engagement (no definitive transaction concluded as of June 18, 2026), an unsuccessful position in the Insignia Financial three-way (BGH was not the winning bidder), and continued ownership of NAVITAS (alongside Australian Super and Rod Jones consortium since 2019). BGH has historically been a buy-and-hold investor with longer hold periods than typical international sponsors. Confidence: HIGH on AUM and fund vintage; LOW on Fund III specifics, which were not definitively closed at the cut date.

Pacific Equity Partners (PEP)

Pacific Equity Partners is the most active Australian-domestic mega-cap sponsor in the cut window. Fund VII held a first close above A$1.5 billion in April 2024 and reached final close at A$3.2 billion (well above the A$3 billion target) in 2025 (ION Analytics on PEP Fund VII close; PEI on hard cap).

Fund VII deployments include FMH Group supply chain and logistics (March 2025), SG Fleet fleet management across Australia, New Zealand, and UK (April 2025), a 50 percent stake in Opal Healthcare (May 2025, repositioning aged care into a co-investment structure with G.K. Goh), and the A$1.1 billion bid for Johns Lyng insurance repair services (accepted June 2025 pending close). PEP also continued Fund VI exit work through 2025. PEP’s typical hold period is five to seven years, with exit pathways predominantly via secondary PE sale or ASX IPO. Confidence: HIGH.

Quadrant Private Equity

Quadrant is the most prolific Australian mid-market sponsor by volume, having raised more than 15 funds with cumulative commitments above A$10 billion since inception (Quadrant funds page; Wikipedia Quadrant). Fund-level data for Fund VIII is partially gated behind LP-only channels. Quadrant ownership of Affinity Education (since 2021, 250+ centres) continues as the dominant childcare position, and Quadrant has been active across services and consumer through 2024 to 2026. Confidence: MEDIUM (fund-specific data partially gated).

Allegro Funds

Allegro Funds is the Australian special-situations specialist. Fund IV (A$750 million capital commitments, in deployment) recorded a sequence of complex carve-out and turnaround deals. Symbos Australia Holdings (BPO) closed March 2024. BE Campbell, one of Australia’s top three pork and value-added meat processors (13 percent market share, two Western Sydney facilities, more than 750 staff) closed August 2025. Fantastic Furniture closed February 2026 as the sixth investment for Fund IV. Allegro launched Fund V targeting up to A$900 million (AgriInvestor on Fund V target). Scyne Advisory (post PwC government consulting carve-out) is the other notable platform. Confidence: HIGH.

Crescent Capital Partners

Crescent Capital Partners has run seven core PE funds since 2000 with A$4.5 billion AUM and a healthcare-heavy portfolio mix (healthcare represents 45 percent of historical deal volume) (Crescent website; CB Insights Crescent profile). The proposed A$303 million take-private of Pacific Smiles Group (announced 2024) is the headline dental roll-up position. Crescent also acquired Billi (the UK boiling and chilled water tap manufacturer) in December 2025. Confidence: HIGH on AUM and headline deals; MEDIUM on Fund VIII close (not located).

Anchorage Capital Partners

Anchorage Capital Partners is the Australian restructuring specialist. Fund III closed at A$360 million in 2017; Fund IV closed at US$327 million in 2023 (AVCJ on Fund IV close; Wikipedia Anchorage). Firm AUM exceeds A$1 billion. Recent activity includes the ENTAG strategic investment (November 2025), Rubicon8 add-on, and the HMA International scheme of arrangement in 2026. Anchorage runs a deep operational improvement playbook and typically targets equity contributions of 30 to 50 percent of total enterprise value. Confidence: HIGH.

Adamantem Capital

Adamantem Capital was founded by ex-Pacific Equity Partners principals Anthony Kerwick and Rob Koczkar. Fund I closed in 2017; Fund II is A$800 million-plus AUM and was more than 60 percent deployed by mid 2024. The Environmental Opportunities Fund reached final close in July 2025 with CEFC as cornerstone investor (ION Analytics PE Spotlight Adamantem; Adamantem EOF release; New Private Markets on EOF close; CEFC EOF cornerstone).

Portfolio highlights include the Plena Healthcare exit to Australian Unity at A$70 million (jointly with Liverpool Partners), Linen Services Australia, NAK Hair, and Advara Heartcare. Confidence: HIGH on fund close dates and portfolio; MEDIUM on Fund II final close, which was not located.

Pemba Capital Partners

Pemba is the most distinctive Australian LMM sponsor by virtue of its buy-and-build franchise focus and disciplined sector concentration. Fund VI closed oversubscribed at A$625 million plus a 2024-vintage Smaller Opportunities Fund at A$40 million (Reinsurance News on Pemba-Hunter; Pemba investments page). Active portfolio includes Rennie (sustainability advisory acquired 2024), Stannards accounting, Sequana, and Hunter Premium Funding (closed May 2025, carved out from Allianz Australia). Pemba’s typical equity contribution is 60 to 75 percent of enterprise value, with debt kept materially below the Australian LMM norm. Confidence: HIGH.

10. Cluster B: Pure lower middle market specialist Australian sponsors

Next Capital

Next Capital closed Fund V at A$375 million in 2022 (PE Insights on Next Capital V; Vantage on Fund V). Recent activity includes the GlobeWest controlling stake (March 2024) and Zenith Payments controlling stake (September 2024). Next Capital targets consumer, services, and business services platforms in the A$10 million to A$40 million EBITDA band. Confidence: HIGH.

Five V Capital

Five V Capital is the Sydney-based growth and technology specialist with A$3.3 billion firm AUM. Fund V closed at A$770 million and the Frontier Fund I reached A$325 million hard cap (Gilbert and Tobin on Fund V; Gilbert and Tobin on Frontier mid-market fund).

Recent activity includes Habit Health (May 2024), APP Group sale to Bureau Veritas (November 2024), Questas Corporate (April 2025), and Ordermentum at A$55 million (May 2026). Five V is positioned as the most technology-weighted Australian LMM sponsor and is the most likely platform partner for SaaS and B2B technology founders evaluating a partial sale. Confidence: HIGH.

Liverpool Partners

Liverpool Partners has run multiple funds since 2012 with a sub-A$100 million enterprise value focus (Liverpool Partners CB Insights profile; Liverpool Tracxn profile). Active deals include the Plena Healthcare exit to Australian Unity A$70 million (with Adamantem), the academyEX exit in July 2025, and Embrace Fertility in April 2026. Liverpool is the most consistent sub-A$50 million enterprise value Australian sponsor. Confidence: HIGH.

Mercury Capital

Mercury Capital runs a co-invest and recycling model rather than a traditional fund-by-fund cadence. Mercury Capital No.1 Fund has been fully exited (Mercury portfolio; Bloomberg profile). Recent activity includes Findex 42 percent (April 2024), Fyfe 60 percent (April 2024), JMC 60 percent (October 2024), Forsyth Barr 25 percent (September 2025), Paramount 50 percent (December 2025), and Carabiner Architects (December 2025). Mercury’s distinctive feature is willingness to take significant minority positions, which makes it the natural partner for founders wanting growth capital without ceding control. Confidence: HIGH.

ROC Partners

ROC Partners has deployed A$9.5 billion across more than 600 investments and runs a secondaries franchise top-ranked by HEC and Dow Jones (ROC website; ROC about us; ROC secondaries). ROC’s direct co-invest sleeve sits alongside ANZ GPs on lower middle market transactions, and the secondaries franchise has been increasingly active on continuation vehicles as Australian sponsors face longer exit timelines. ROC’s direct ticket band is A$5 million to A$50 million EBITDA. Confidence: HIGH.

Catalyst Direct Capital Management and Catalyst Private Equity

Catalyst Direct runs a PIPE and direct hybrid fund, distinct from the separate Catalyst Private Equity small-cap-focused vehicle. Public 2024 to 2026 deal disclosure is limited for both. Catalyst Direct is occasionally referenced as a co-investor on listed-adjacent positions. Confidence: MEDIUM (Catalyst Direct) and LOW (Catalyst PE).

CPE Capital (formerly CHAMP)

CHAMP III closed at A$1.5 billion in 2010; the firm rebranded to CPE Capital in 2019 (AVCJ on CHAMP rebrand to CPE; CPE Capital release). Activity has slowed materially since the rebrand, with limited new platform deals identified in the 2024 to 2026 window. Confidence: MEDIUM.

The Growth Fund Group, Equity Partners, Marlin Equity Partners ANZ

Limited public 2024 to 2026 deal disclosure. The Growth Fund Group is family-office adjacent; Equity Partners has shown limited recent PE activity; Marlin Equity Partners runs an Australia and New Zealand desk for technology and SaaS but has limited disclosed Australian platforms in the window. Tracked as “likely active” but not confirmed deal by deal. Confidence: LOW.

11. Cluster C: International sponsors with Australia mandate

KKR

KKR runs Australia from its Sydney office and has historically been one of the most active international sponsors in Australian PE. The KKR Perpetual termination in February 2025 (covered in Section 4) is the headline event. KKR also took an HMC Energy Transition platform position in 2025 and has maintained a significant private credit presence through Pemberton Asset Management adjacencies. Confidence: HIGH.

Bain Capital

Bain Capital Australia (Sydney) is the most aviation-active international sponsor in Australia via Virgin Australia (ASX relisting completed in November 2024 and 2025 windows). The Estia Health exit to Stonepeak at A$2.5 billion (announced February 2026, expected close H2 2026) is the headline aged-care PE exit (Bain Capital release on original Estia deal). Bain bought Estia for A$838 million in 2023 and grew the portfolio from 73 homes (6,720 places) to 93 homes (9,250 places). Bain also participated in the Insignia Financial three-way bidding war (withdrawn after due diligence). Confidence: HIGH.

TPG Capital

TPG Asia runs the Australia mandate. Recent activity includes the Novotech US$760 million financing in March 2025 with GIC and Temasek joining TPG (Novotech release on funding; DealStreetAsia on US$760m financing). Greencross (TPG and Carlyle joint position) was evaluating an ASX relisting at a USD 3.75 billion valuation through 2025. Confidence: HIGH.

Brookfield

Brookfield Australia (Sydney) was the largest international sponsor by AUM in Australia prior to the Healthscope receivership. Existing portfolio positions include Origin Energy (closed 2023), AusNet (2021 prior), and La Trobe Financial (2022 prior). Brookfield participated in the Insignia Financial three-way bidding war (withdrew at A$4.60 per share). The Healthscope failure is the dominant 2025 event for Brookfield Australia and has reset internal underwriting hurdles. Confidence: HIGH.

CVC Capital Partners

CVC Asia Fund VI closed at US$6.8 billion in 2024 (50 percent larger than Fund V at US$4.5 billion) (CVC Asia VI fund news). The headline Australian deal is CVC joining PAG on Australian Venue Co at a 45 percent stake and A$2.1 billion group valuation in August 2025 (CVC AVC release; Hotel Conversation on AVC; Business News Australia on AVC). Confidence: HIGH.

Blackstone, Apollo, Affinity Equity Partners, L Catterton Asia

All four have a stated Australia mandate and active presence through 2024 to 2026, but PE buyout activity has not surfaced at the platform-deal level within the cut window. Blackstone and Apollo are confirmed present via private credit and real estate, with PE buyout disclosure limited. Affinity Equity Partners and L Catterton Asia run pan-Asia LMM and mid-market mandates with Australian deal flow but limited 2024-2026 disclosure. Confidence: MEDIUM.

PAG

PAG was the original PE owner of Australian Venue Co and partially sold to CVC in August 2025 at the A$2.1 billion group valuation, retaining a co-control position. Confidence: HIGH.

Stonepeak, EQT Partners, CC Capital Partners, Paine Schwartz Partners

These four international sponsors completed defining Australian transactions in the cut window. Stonepeak bought Estia Health from Bain at A$2.5 billion (announced February 2026, close H2 2026). EQT acquired VetPartners (267-clinic network, 1,300+ vets) in January 2025 from US-based National Veterinary Associates at an initial rumoured A$1.4 billion bid (PE Insights on EQT VetPartners; Business News Australia on EQT VetPartners shake-up). CC Capital Partners won Insignia Financial at A$3.3 billion (covered in Section 5). Paine Schwartz Partners (with Driscoll’s and BCI) completed the Costa Group take-private at A$3.20 per share in February 2024 (Paine Schwartz Costa release; Costa Group announcement; PE Hub close; Agri Investor on shareholder vote). Confidence: HIGH.

12. 2024 to 2026 deal flow timeline

2024 highlights

• February 2024. Paine Schwartz Partners, Driscoll’s, and BCI completed the Costa Group take-private at A$3.20 per share, delisting the largest Australian horticultural business (berries, citrus, mushrooms, avocados, tomatoes).
• March 2024. Allegro Fund IV acquired Symbos Australia Holdings (BPO). Next Capital took a controlling stake in GlobeWest.
• April 2024. Mercury took 42 percent of Findex (mid-market accounting and advisory) and 60 percent of Fyfe (engineering).
• May 2024. Five V Capital acquired Habit Health.
• July 2024. Saint-Gobain completed the CSR take-private at A$4.3 billion. Seven Group completed the Boral take-private at A$1.5 billion.
• September 2024. Next Capital took a controlling stake in Zenith Payments.
• October 2024. Mercury took 60 percent of JMC.
• November 2024. ACCC cleared the Sigma Healthcare and Chemist Warehouse A$8.8 billion merger (subject to court-enforceable undertakings) (ACCC public competition assessment PDF). Bain Capital began the Virgin Australia ASX relisting process. Five V Capital sold APP Group to Bureau Veritas.
• December 2024. News Corp and Telstra agreed to sell Foxtel to DAZN at an enterprise value of A$3.4 billion (more than 7x FY24 EBITDA) (DAZN release on closing). Crescent Capital acquired Billi (UK water tap manufacturer). The federal government implemented a 10 percent Worker Retention Payment for childcare workers, rising to 15 percent in December 2025.

2025 highlights

• January 2025. EQT acquired VetPartners (267 clinics, 1,300+ vets) from National Veterinary Associates at A$1.4 billion initial rumoured price. CC Capital submitted the first A$2.87 billion bid for Insignia Financial.
• February 2025. KKR terminated the A$2.175 billion Perpetual wealth and corporate trust deal following the negative ATO ruling. Palisade Intera Renewables acquired the Limestone Coast North 500 MWh BESS (A$460 million).
• March 2025. TPG, GIC, and Temasek closed the Novotech US$760 million financing. PEP acquired FMH Group (supply chain and logistics).
• April 2025. PEP acquired SG Fleet (A$1.2 billion-plus enterprise value across Australia, New Zealand, and UK). Five V Capital acquired Questas Corporate. Macmahon Holdings secured A$172 million of underground gold-copper mining service contracts at Deflector and Genesis Minerals’ Gwalia and Ulysses projects (International Mining on Macmahon contracts; Sharecafe; Australian Mining Review).
• April 2025. Foxtel-DAZN closed after FIRB and ACCC clearance (Variety on Murdoch sale close).
• May 2025. Healthscope entered receivership on May 26, 2025. McGrathNicol appointed receivers; equity wiped out. PEP took 50 percent of Opal Healthcare alongside G.K. Goh. Pemba completed the Hunter Premium Funding carve-out from Allianz Australia.
• June 2025. PEP submitted A$1.1 billion bid for Johns Lyng insurance repair services (accepted, pending close).
• July 2025. CC Capital signed the scheme implementation deed for Insignia Financial at A$4.80 per share, A$3.3 billion total. Liverpool Partners exited academyEX. Adamantem closed the Environmental Opportunities Fund.
• August 2025. CVC joined PAG on Australian Venue Co at 45 percent, A$2.1 billion group valuation. Allegro Fund IV acquired BE Campbell pork processor.
• September 2025. Mercury took 25 percent of Forsyth Barr (NZ wealth, sometimes counted in ANZ portfolios).
• November 2025. UniSuper anchored Macquarie Asset Management infrastructure-adjacency strategy at US$500 million. Anchorage made an ENTAG strategic investment.
• December 2025. Mercury took 50 percent of Paramount and acquired Carabiner Architects.

2026 highlights through June 18

• February 2026. Bain Capital announced the A$2.5 billion exit of Estia Health to Stonepeak with Axight as minority co-investor (close expected H2 2026). Allegro Fund IV acquired Fantastic Furniture as its sixth investment.
• April 2026. Liverpool Partners acquired Embrace Fertility. Palisade Intera Renewables acquired the 960 MWh Summerfield battery from Copenhagen Infrastructure Partners’ CI V fund (Energy Storage News on Summerfield).
• May 2026. Five V Capital acquired Ordermentum at A$55 million.
• June 2026. Cut date for this tracker: June 18, 2026.

Macro ASX delisting cadence

ASX delistings ran above 150 in FY24 versus 119 in FY23, marking a sustained step-up in the PE take-private cadence (InvestorDaily on delistings; InvestorDaily on FY24 exit volume). The trade-buyer take-privates of CSR (Saint-Gobain), Boral (Seven Group), and Alumina (Alcoa) removed three high-quality industrial comps. Confidence: HIGH.

13. Multiples and Australian mid-market discount

Grant Thornton Dealtracker 2025

Grant Thornton’s tenth Dealtracker, covering 18 months from July 1, 2023 to December 31, 2024, reports median deal EBITDA multiples at 8.3x, slightly above the 8.1x long-term average (Grant Thornton Dealtracker 2025 PDF; Grant Thornton press release). Industrials remains the deepest sector at 31 percent of deal volume. Technology median EV/EBITDA reached 11.4x, the highest of any sector. Small and mid-market deals (under A$100 million enterprise value) dominate volumes. Confidence: HIGH.

Corrs Chambers Westgarth 2025 PE trends

Corrs notes that mid-market transactions in the A$50 million to A$250 million range have shown strong resilience, and that EBITDA multiples in technology and business services have stepped up over the trailing 12 months (Corrs Australian PE Trends 2025; Corrs M&A 2026 Outlook; Mondaq republish). PE is increasingly focused on platform plays with operational improvement angles rather than financial engineering, reflecting both the rate environment and the new ACCC mandatory merger regime. Confidence: HIGH.

Indicative LMM multiple bands by sector

The bands below are CT triangulation from public deal commentary, Grant Thornton sector medians, Corrs mid-market read, and individual transactions cited above. These are ranges, not precision figures, and should not be quoted in client materials without further triangulation.

Confidence: MEDIUM (CT triangulation from secondary sources).

ASX listed comps versus private LMM gap

Triangulating ASX small-mid cap EV/EBITDA against private LMM transactions yields a structural discount of roughly 1.5x to 2.5x EBITDA in favour of public markets in healthcare, mining services, and consumer. This is the inverse of the US private control premium and reflects the depth of the super fund bid for ASX names. Implication: exits via ASX IPO can carry a more attractive headline multiple than secondary PE sale at the A$200 to A$400 million enterprise value band, provided the issuer can support listed-company governance and free float. Confidence: MEDIUM.

14. Sector consolidation themes

Aged care and retirement

Bain Capital’s exit of Estia at A$2.5 billion to Stonepeak benchmarks the upper end. PEP’s 50 percent Opal Healthcare stake (May 2025) is the other live mega-cap aged-care position. The Healthscope receivership has compressed sponsor appetite for hospital roll-ups, but residential aged care continues to attract permanent-capital sources (Stonepeak, Goh, Macquarie Infrastructure) more than traditional buyout sponsors. Regis Healthcare remains ASX-listed; Japara was absorbed by Calvary in 2021. Confidence: HIGH.

Childcare

Quadrant continues to own Affinity Education (since 2021, 250+ centres). G8 Education remains ASX-listed. Goodstart Early Learning is the not-for-profit market leader. The 2024 Worker Retention Payment from the federal government (10 percent in December 2024 rising to 15 percent in December 2025) materially reshaped childcare unit economics and accelerated mid-tier consolidation. Embark Early Education (Chris Scott-led, A$25 million add-on) signalled fresh entry. The post-2026 ACCC mandatory merger regime captures childcare roll-ups, which compresses the build-up economics for new platforms but rewards Quadrant’s incumbent scale. Confidence: HIGH.

Veterinary

EQT (VetPartners 267 clinics), TPG and Carlyle (Greencross, evaluating relisting), VetGroup, Vetwest, and a long tail of independent practices. The sector is the most consolidated of the Australian healthcare verticals. EQT immediately began protocol standardisation and supplier renegotiation at VetPartners post-acquisition. Greencross was evaluating an ASX relisting at a USD 3.75 billion valuation through 2025. Confidence: HIGH.

Healthcare services (dental, allied, pathology, imaging)

The Australian dental market remains a sub-A$13 billion sector primarily funded by out-of-pocket spending, with 90 percent of clinics still owner-operated (BDO dental practice trends). Headline LMM transactions include New Zealand’s Abano Healthcare buying 1300SMILES at A$165 million (2022), and Crescent Capital’s proposed A$303 million Pacific Smiles Group take-private (announced 2024). Private practice transactions are clearing in the 4x to 5x EBITDA range at the small end of the market, with consolidator multiples of 7x to 9x at scale, a notable arbitrage spread that drives sponsor roll-up economics.

The new ACCC mandatory merger notification regime, effective January 1, 2026, explicitly captures serial roll-ups in dental, GP, pathology, imaging, allied health, and specialist networks. Avant Law issued explicit practical guidance for medical executives, signalling that the regulator’s expectation is for sponsor consolidators to notify cumulative add-on programmes (Avant Law on new ACCC regime). Confidence: HIGH.

Mining services and maintenance

Pemba, Catalyst Direct, and Allegro (special-situations carve-outs) dominate the sponsor side. Macmahon and Perenti are the listed strategic acquirers. Bowen Basin coal services and Pilbara iron ore camp-and-catering services are sponsor-favoured because of contract visibility. Pemba Fund VI has been particularly active around the Mackay-Bowen Basin nexus and Pilbara-adjacent platforms in 2024 to 2025. Confidence: HIGH on platforms; MEDIUM on per-deal multiples.

Defence and critical infrastructure

This sector is structurally constrained by FIRB tightening. The AUKUS submarine programme and the broader defence industrial base build-out has attracted attention from Allegro and Quadrant via tier-2 and tier-3 supply chain plays, but headline transactions remain rare. The combination of FIRB scrutiny and ITAR-equivalent export controls keeps foreign sponsors at arm’s length. Confidence: MEDIUM.

Renewables and battery storage

Q1 2025 Australian large-scale battery storage investment hit A$2.4 billion across six projects financial-committed, delivering 1.5 GW storage capacity and 5 GWh of energy output, the second-highest quarterly figure on record (Energy Monitor on Q1 2025; Carbon Credits on A$2.4bn boom). Palisade Intera Renewables acquired the Limestone Coast North 500 MWh BESS (February 2025, A$460 million) and the 960 MWh Summerfield battery from Copenhagen Infrastructure Partners’ CI V fund (April 2026). KKR took its HMC Energy Transition platform position, and Aula acquired a solar and BESS portfolio from Lightsource bp. Brookfield (Origin Energy retail and generation), KKR (HMC Energy Transition), Palisade (Intera Renewables platform), and Macquarie Asset Management (green energy and climate fund with UniSuper anchor) are the named sponsors with the deepest renewables benches. Battery storage is the single highest-velocity sector by deal count in 2025 to 2026. Confidence: HIGH.

Food and agribusiness

Paine Schwartz, Driscoll’s, and BCI (Costa Group take-private A$3.20 per share, February 2024), Allegro (BE Campbell pork August 2025), and Tassal (now Cooke Inc post 2022). Sealord and AACo remain in current ownership structures unchanged. The Costa Group take-private remains the headline anchor for Australian fresh produce PE. Confidence: HIGH.

Education and training

Affinity Education (Quadrant). NAVITAS (BGH, Australian Super, Rod Jones consortium since 2019). Study Group Australia remains under Ardian since 2019. International student visa policy changes through 2024 to 2026 created near-term volatility in the higher education segment but increased deal flow at the vocational and mid-career skills level. Confidence: MEDIUM.

Professional services

Mercury (Findex 42 percent, Forsyth Barr 25 percent, Carabiner Architects), Pemba (Stannards accounting, Sequana, Rennie sustainability), Allegro (Scyne Advisory post PwC carve-out). The post-PwC Australia tax leak scandal in 2023 created a meaningful carve-out flow that has tailed into 2024 and 2025. Confidence: HIGH.

Financial services (broking, wealth, super, insurance)

CC Capital’s Insignia A$3.3 billion take-private (the headline 2025 deal), BGH’s continued financial services interest, Pemba’s Hunter Premium Funding (closed May 2025), Mercury Findex, and the KKR Perpetual failure. Wealth management platforms and payments infrastructure are the most active sub-segments. Confidence: HIGH.

Hospitality

CVC and PAG (Australian Venue Co 45 percent each, A$2.1 billion group valuation August 2025). The sector benefits from controlled supply (state liquor licence regimes), residential migration tailwind, and predictable wagering revenue overlay. Confidence: HIGH.

Fintech and payments

Next Capital (Zenith Payments controlling stake September 2024) and Mercury (Findex adjacent to wealth payments) are the most active. Block / Afterpay sits outside the LMM. The sector has been quiet on PE buyouts versus venture but is increasingly an exit destination for late-stage venture as the IPO window remains narrow. Confidence: MEDIUM.

15. Six contrarian findings

Finding 1: Super fund direct PE bids compress LMM returns at the A$300 million-plus enterprise value band but leave sub-A$250 million effectively uncontested

AustralianSuper, UniSuper, Aware Super, and Australian Retirement Trust all run direct PE programmes with effective minimum equity cheques in the A$100 to A$250 million range. The result is bimodal: above A$300 million enterprise value, sponsors compete directly with super funds and accept 12 to 15 percent net IRR; below A$250 million enterprise value, super funds rarely participate, and the sponsor profile of 18 to 22 percent net IRR holds. The gap zone is A$250 to A$400 million enterprise value where super fund co-investment alongside an Australian GP is the most stable bid structure. This bimodality explains why Pemba, Liverpool, Anchorage, and Next Capital have defended their LMM franchises while upper-mid mandates face fee pressure (Investment Magazine 2026; Aware Super profile). Confidence: HIGH.

Finding 2: FIRB tightening on healthcare and critical infrastructure has changed who can underwrite Australian deals

The 2024 reforms split FIRB processing into low-risk fast track and high-risk slow track. Healthcare, data businesses, critical infrastructure, and defence-adjacent targets are slow track and frequently attract behavioural undertakings even where the monetary threshold is not triggered. For US and UK sponsors this has added 60 to 120 days to deal timelines versus the 2021 to 2023 baseline and inserted conditionality risk into LBO commitment letters. Domestic Australian sponsors (Pemba, Adamantem, Allegro, Crescent, Mercury, Liverpool) hold a structural advantage on health-services LMM deals because they avoid the FIRB pathway entirely (Bird and Bird FDI review 2024). Confidence: HIGH.

Finding 3: The carry tax position post Bell v FCT is materially worse than US and UK and has hidden cost-of-capital implications for foreign sponsors

Australia has no qualifying-carry regime. ATO defaults to revenue characterisation of carry distributions to GP principals unless the structure clearly qualifies for capital treatment. This contrasts with the UK’s 28 percent qualifying carry rate (rising to 32 percent from April 2025) and the US 23.8 percent long-term capital gain framework. For Australian-domiciled GP principals running offshore funds, the effective marginal tax rate on carry can reach 47 percent (top marginal income plus 2 percent Medicare) versus 28 to 32 percent in the UK and 23.8 percent in the US. The hidden consequence is that Australian senior partners need a higher gross carry pool to deliver the same after-tax outcome as international peers, which compounds with the FIRB friction to push Australian GPs toward higher net fees and slimmer hurdle gates (Tax Institute on Bell v FCT; Grant Thornton on foreign PE tax). Confidence: HIGH on framework; MEDIUM on precise effective rate (fact-specific).

Finding 4: The thin capitalisation overhaul has reset Australian LBO structures away from offshore-parent debt and toward Australian-resident senior debt

The 30 percent Tax EBITDA fixed ratio plus the DDCR provisions effectively end the structure that PE sponsors had relied on of pushing offshore parent shareholder loans into the Australian Newco. Effective from July 1, 2023, this has compressed senior debt ratios at LBO close from a historic 5.5 to 6.0x EBITDA range to roughly 4.5 to 5.0x for typical LMM transactions. The flip-side has been an explosion of Australian private credit. Metrics Credit Partners, La Trobe Financial, Pengana Capital, Ares Australia, and Australian Mutual Bank all materially expanded their unitranche lending books from 2024 forward as the senior LBO debt market opened up to non-bank lenders (PWC on debt deduction rules; ATO new measures portal). Confidence: HIGH.

Finding 5: The Healthscope receivership is a generational hospitals reset that will re-price the entire Australian healthcare sponsor franchise

Brookfield’s A$5.7 billion 2019 acquisition collapsed into a A$1.6 billion senior debt-only outcome by May 2025, with Brookfield equity wiped out. The single largest PE healthcare loss in Australian history. Cascade effects: senior credit funds now require 1.0 to 1.5x tighter maintenance covenants on hospital and residential-care LBOs, banks have largely withdrawn from hospital senior debt, and sponsor equity contributions on aged-care deals are running 50 to 55 percent versus the 35 to 40 percent norm in 2021 to 2022. The PEP-Goh Opal Healthcare partial structure and the Stonepeak-Axight Estia structure both rely on permanent capital co-investors rather than traditional LBO debt (RSM on Healthscope receivership). Confidence: HIGH.

Finding 6: The new ACCC mandatory merger regime materially compresses buy-and-build economics in fragmented healthcare and professional services verticals

The ACCC’s signalling on “creeping acquisitions” makes clear that serial roll-ups in dental, GP, pathology, imaging, allied health, accounting, and veterinary will face notification obligations regardless of individual deal size. The practical result: build-up timelines extend by 60 to 180 days per add-on, transaction costs add A$200,000 to A$500,000 per notification, and the option to fail-fast on opportunistic add-ons disappears. Sponsors that finalised their roll-up programme architecture in 2024 to 2025 (Crescent Pacific Smiles, EQT VetPartners, Quadrant Affinity Education) hold a window-of-opportunity premium versus sponsors trying to start a new platform from late 2025 onward (ACCC merger reform overview; Avant Law for medical executives; Treasury consultation page). Confidence: HIGH.

16. Workforce and super fund LP dynamics

Australian PE LP capital is dominated by superannuation funds, with the largest seven (AustralianSuper, Australian Retirement Trust, Aware Super, UniSuper, Cbus, HESTA, Hostplus) accounting for the majority of domestic LP capital deployed into local sponsors. This LP composition creates two structural workforce dynamics that distinguish Australia from the UK and US PE markets.

First, super fund LPs increasingly run their own direct PE teams that compete with sponsors on the same deals. AustralianSuper’s A$14 billion direct PE allocation, the AustralianSuper US PE team expansion in July 2025, and Aware Super’s European office build all reflect this transition from pure-LP to direct co-bidder. The implication for Australian sponsors is that their largest LPs are also their most aggressive competitors at the upper-mid-market band, which has driven sponsors to either move down-market (Pemba, Liverpool, Mercury, Next Capital) or move offshore for Asian deal flow (BGH Capital Asia mandate, PEP New Zealand and UK platforms).

Second, the Future Fund (Australia’s A$245 billion sovereign wealth fund) maintains a substantial PE allocation but operates with longer-duration, lower-fee mandates than typical commercial LPs. The Future Fund’s PE programme prioritises fee efficiency and has progressively shifted toward separately managed accounts and direct co-investment over commingled blind-pool funds. The Future Fund pattern is replicated by mid-sized industry funds (Cbus, HESTA, Hostplus), which increasingly demand co-investment rights as a condition of primary fund commitment. The net effect is that Australian sponsors face higher effective net fee compression than UK or US peers because the largest domestic LPs have bargaining power to demand co-invest and reduced management fee schedules.

Workforce composition at Australian sponsors mirrors these LP dynamics. Senior partners increasingly run dual mandates (fund deployment plus LP co-invest origination) and the typical Australian GP carries a lower partner-to-portfolio-company headcount ratio than UK or US peers. The post-Healthscope and post-KKR Perpetual environment has also pushed sponsors toward heavier operating partner benches with deep healthcare regulatory, financial services regulatory, and ATO structuring expertise. Confidence: HIGH on dynamics; MEDIUM on precise headcount ratios.

17. Seller-fit matrix

For founders and family owners evaluating an Australian PE process, the seller-fit matrix below maps typical platform profiles to the most likely sponsor cohort. This is a directional tool, not a substitute for advisor counsel.

Founder rollover norms reflect the typical equity continuation that sponsors expect from existing owners across the cycle. Tighter rollover (above 35 percent) typically signals a buy-and-build platform launch where founder continuity is essential to multi-year growth. Lower rollover (below 15 percent) typically signals a full exit or restructuring scenario. Confidence: MEDIUM (process pace and rollover norms are cycle-dependent).

18. Limitations and gap disclosures

The CT Acquisitions research desk applies confidence ratings transparently. The following items in this tracker have not been verified to primary-source HIGH confidence and should be treated with corresponding caution in client materials.

1. BGH Capital Fund III. Secondary sources reference Fund III in fundraising during 2024 to 2025; no definitive close was located. Firm AUM at A$6.8 billion sourced, not Fund III-specific. Confidence: LOW.
2. Quadrant Fund VIII. Fund-level disclosures partially gated. A$10 billion-plus cumulative sourced; Fund VIII-specific size and 2024 to 2026 deal list not triangulated to primary source. Confidence: MEDIUM.
3. Crescent Capital Partners Fund VIII. Crescent states seven core PE funds and A$4.5 billion AUM. No Fund VIII close confirmed. Pacific Smiles A$303 million proposal confirmed; broader Fund VIII deployment list not. Confidence: MEDIUM.
4. Adamantem Capital Fund II final close. Fund II in deployment (60 percent-plus as of mid 2024); definitive final close date not located. EOF final close July 2025 sourced. Confidence: MEDIUM.
5. Catalyst Direct, Catalyst PE, The Growth Fund Group, Equity Partners, Marlin Equity Partners ANZ. Limited 2024 to 2026 deal disclosure. Tracked as “likely active” but not confirmed deal by deal. Confidence: LOW.
6. Carlyle Australia and Affinity Equity Partners. Limited Australia-specific 2024 to 2026 platform disclosures. Greencross (TPG plus Carlyle) sourced via secondary commentary on potential relisting only. Confidence: MEDIUM.
7. Apollo and Blackstone Australia 2024 to 2026 buyouts. Both confirmed present via private credit and real estate; PE buyout activity not surfaced at deal level within window. Confidence: MEDIUM.
8. Super fund direct PE allocation precision. BCG A$185 billion 2025 projection sourced via Investment Magazine secondary cite. AustralianSuper A$14 billion direct PE allocation via Super Review; precise current deployment percentage not verified. Confidence: MEDIUM.
9. ABS / ATO Australian SME succession demographics. 1.4 million family business figure widely cited via FBA-KPMG; specific cut date and methodology not independently re-verified. Confidence: MEDIUM.
10. Brisbane / Sydney / Melbourne deal split. 50 to 55 / 25 to 30 / 8 to 12 percent based on Mergermarket and AFR tracker commentary, not a single primary release. Directional. Confidence: LOW.
11. Section 13 multiple bands. CT triangulation from Grant Thornton Dealtracker median commentary plus deal cites. Not primary-source benchmark ranges. Confidence: MEDIUM.
12. Carry tax marginal rate. The UK 28 percent, US 23.8 percent, and Australia 47 percent figures reflect headline frameworks. Treat 47 percent as a ceiling for Australia, not a uniform rate. Confidence: MEDIUM.
13. ACCC mandatory merger regime January 1, 2026 effective date. Confirmed via Treasury consultation and ACCC reform overview. Precise thresholds and notification gates for serial acquirers remain subject to implementation guidelines finalised at cut date. Confidence: HIGH on regime; MEDIUM on serial-acquirer thresholds.

19. Related CT Acquisitions research

• European PE buyer market, 2026 update. Companion master tracker covering EU mega-cap and pan-European PE buyers active in 2024 to 2026.
• UK PE buyer market, 2026 update. Wave 5 sibling covering UK middle-market and lower middle market sponsors, including post-Budget 2024 carry tax framework comparisons referenced in Finding 3.
• DACH PE buyer market, 2026 update. Wave 5 sibling covering Germany, Austria, and Switzerland sponsors.
• Nordics PE buyer market, 2026 update. Wave 5 sibling covering Sweden, Norway, Denmark, and Finland sponsors.
• Benelux PE buyer market, 2026 update. Wave 5 sibling covering Belgium, the Netherlands, and Luxembourg sponsors.
• France PE buyer market, 2026 update. Wave 5 sibling covering French sponsors with relevant comparative read on family-office and permanent-capital co-investment.
• Canada PE buyer market, 2026 update. Wave 6 sibling drafted in parallel to this Australian tracker, covering Canadian LMM and pension-fund direct PE dynamics.
• CT Acquisitions Platform Map. Global view of active sponsors and roll-up platforms across CT research coverage.

20. Sources

Primary regulatory and policy sources

• ATO new international tax measures
• ATO CGT discount overview
• foreigninvestment.gov.au monetary thresholds
• ACCC merger reform overview
• Treasury merger reform consultation 2024
• ACCC Sigma Chemist Warehouse public competition assessment PDF
• ACCC supermarket case September 2024
• ABS Counts of Australian Businesses

Industry and AUM data

• AIC 2025 Australian Private Capital Yearbook PDF
• Preqin Australia 2025 Yearbook
• Financial Standard A$139bn summary
• Grant Thornton Dealtracker 2025 PDF
• Corrs Australian PE Trends 2025
• Corrs M&A 2026 Outlook

Tax and regulatory analysis

• PwC on Australia’s thin capitalisation regime
• RSM Global summary on earnings-based regime
• Ashurst on senate amendments
• Hall Chadwick Thincap paper 2024
• MinterEllison on FIRB reform
• Lexology FDI 2025 review
• McCullough Robertson on 2025 indexation
• White and Case Australia FDI 2025
• Bird and Bird FDI year in review
• Tax Institute on Bell v FCT
• Grant Thornton on foreign PE tax
• Avant Law on new ACCC regime

Sponsor and fund close announcements

• ION Analytics on PEP Fund VII
• PEI on PEP hard cap
• Wikipedia BGH Capital
• PEI BGH institution profile
• Quadrant funds page
• Wikipedia Quadrant
• AgriInvestor on Allegro Fund V
• Crescent Capital website
• CB Insights Crescent profile
• AVCJ on Anchorage Fund IV
• Wikipedia Anchorage
• ION Analytics PE Spotlight Adamantem
• Adamantem EOF final close release
• New Private Markets on EOF close
• CEFC EOF cornerstone
• Reinsurance News on Pemba-Hunter
• Pemba investments page
• PE Insights on Next Capital V
• Vantage on Next Capital V
• Gilbert and Tobin on Five V Fund V
• Gilbert and Tobin on Five V Frontier Fund
• CB Insights Liverpool Partners
• Tracxn Liverpool Partners
• Mercury portfolio
• Bloomberg Mercury profile
• ROC Partners website
• ROC about us
• ROC secondaries
• AVCJ on CHAMP rebrand to CPE
• CPE Capital release
• CVC Asia VI fund news

Deal-level sources

• Paine Schwartz Costa release
• Costa Group announcement
• PE Hub Costa close
• Agri Investor on Costa shareholder vote
• DAZN release on Foxtel closing
• News Corp on Foxtel agreement
• Variety on Foxtel sale close
• Inside Ageing on Estia-Stonepeak
• Weekly Source on Estia exit
• Bain Capital original Estia release
• MarketScreener Insignia coverage
• Money Management on CC Capital victory
• Investment Magazine on Insignia A$3.3bn deal
• Capital Brief on KKR Perpetual
• US News on Perpetual termination
• Money Management on Perpetual profit fall
• Wealth Briefing Asia on KKR-Perpetual
• RSM Australia on Healthscope receivership
• Manly Observer on Healthscope
• Wikipedia Healthscope
• PE Insights on EQT VetPartners
• Business News Australia on EQT VetPartners
• Novotech release on TPG financing
• DealStreetAsia on Novotech US$760m
• CVC AVC release
• Hotel Conversation on AVC
• Business News Australia on CVC AVC
• International Mining on Macmahon
• Sharecafe on Macmahon
• Australian Mining Review on Macmahon
• Energy Monitor on Australia BESS Q1 2025
• Carbon Credits on A$2.4bn boom
• Energy Storage News on Summerfield BESS
• SmallCaps on Sigma ACCC green light
• Gilbert and Tobin on Sigma ACCC
• BDO dental practice trends
• InvestorDaily on ASX delistings
• InvestorDaily on FY24 exits

Super fund and LP sources

• Investment Magazine BCG projection
• Super Review on AustralianSuper A$14bn
• PR Newswire on AustralianSuper US PE hire
• Investment Magazine 2026 on AustralianSuper PE expansion
• Investment Magazine on UniSuper-Macquarie
• Aware Super profile
• KPMG and FBA Family Business Survey

21. Frequently asked questions

About the author

This tracker was researched and compiled by the CT Acquisitions research desk, headed by Christoph Totter. CT Acquisitions provides sell-side advisory and PE buyer mapping for lower middle market founders and family business owners across North America, Europe, and Asia-Pacific. The Australian tracker is part of CT’s Wave 6 research series, sibling to the Canada PE buyer tracker drafted in parallel. CT Acquisitions internal reviews and update cadence: quarterly. Last verified: June 18, 2026.